Envestnet Portfolio Solutions Inc. lessened its position in shares of Teradyne, Inc. (NASDAQ:TER – Free Report) by 26.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 6,561 shares of the company’s stock after selling 2,351 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Teradyne were worth $826,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently made changes to their positions in the company. State Street Corp lifted its position in shares of Teradyne by 5.4% during the 3rd quarter. State Street Corp now owns 6,880,148 shares of the company’s stock valued at $921,458,000 after buying an additional 350,002 shares during the last quarter. Van ECK Associates Corp lifted its holdings in Teradyne by 59.9% during the 4th quarter. Van ECK Associates Corp now owns 4,928,143 shares of the company’s stock worth $620,552,000 after purchasing an additional 1,846,079 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Teradyne by 5.5% during the 3rd quarter. Geode Capital Management LLC now owns 4,011,131 shares of the company’s stock worth $535,484,000 after purchasing an additional 209,868 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Teradyne by 16.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,825,897 shares of the company’s stock worth $355,837,000 after purchasing an additional 393,175 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Teradyne by 7.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 2,390,896 shares of the company’s stock worth $302,582,000 after purchasing an additional 157,838 shares in the last quarter. Hedge funds and other institutional investors own 99.77% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on TER. Vertical Research began coverage on Teradyne in a report on Friday, March 7th. They set a “buy” rating and a $135.00 price objective on the stock. Susquehanna dropped their price objective on Teradyne from $165.00 to $155.00 and set a “positive” rating on the stock in a report on Wednesday, March 12th. Citigroup dropped their price objective on Teradyne from $130.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, March 12th. JPMorgan Chase & Co. dropped their price objective on Teradyne from $145.00 to $120.00 and set an “overweight” rating on the stock in a report on Wednesday, March 12th. Finally, Northland Securities lowered their price target on Teradyne from $154.00 to $140.00 and set an “outperform” rating on the stock in a report on Friday, January 31st. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $121.44.
Insider Buying and Selling
In related news, CFO Sanjay Mehta sold 1,384 shares of the firm’s stock in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $111.49, for a total transaction of $154,302.16. Following the transaction, the chief financial officer now directly owns 36,576 shares in the company, valued at $4,077,858.24. This trade represents a 3.65 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gregory Stephen Smith sold 3,080 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $130.00, for a total value of $400,400.00. Following the transaction, the chief executive officer now owns 74,660 shares in the company, valued at approximately $9,705,800. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,479 shares of company stock worth $1,013,134 in the last ninety days. 0.36% of the stock is owned by insiders.
Teradyne Trading Down 0.8 %
Shares of Teradyne stock opened at $87.51 on Monday. The firm has a market capitalization of $14.15 billion, a PE ratio of 26.28, a price-to-earnings-growth ratio of 2.83 and a beta of 1.46. The business’s 50-day moving average price is $112.72 and its 200-day moving average price is $118.67. Teradyne, Inc. has a 12 month low of $82.98 and a 12 month high of $163.21.
Teradyne (NASDAQ:TER – Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. Teradyne had a return on equity of 19.08% and a net margin of 19.23%. As a group, analysts predict that Teradyne, Inc. will post 3.88 earnings per share for the current fiscal year.
Teradyne Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 14th were given a dividend of $0.12 per share. The ex-dividend date was Friday, February 14th. This represents a $0.48 annualized dividend and a yield of 0.55%. Teradyne’s payout ratio is 14.41%.
Teradyne Company Profile
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Read More
- Five stocks we like better than Teradyne
- Which Wall Street Analysts are the Most Accurate?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Trading Halts Explained
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TER – Free Report).
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.